( ISSN 2380-548X ) SciForschenOpen HUB for Scientific Research International Journal of Endocrinology and Metabolic Disorders Review Article Volume: 1.4 Open Access Received date: 08 October 2015; Accepted date: Guideline for the Management of Insulin 27 October 2015; Published date: 30 October 2015. Resistance Citation: Govers E, Slof E, Verkoelen H, Ten Hoor-Aukema NM, KDOO (2015) Guideline for the Management of Insulin Resistance. Int J Endocrinol Govers E1, Slof E2, Verkoelen H3, Ten Hoor-Aukema NM4 and Knowledge Centre Metab Disord 1(4): doi http://dx.doi.org/10.16966/2380- for Dietitians for Prevention and Management of Overweight and Obesity (KDOO) 548X.115 1 Chair to ESDN Obesity of the European Federation of Associations of Dietitians (EFAD), Primary Care Copyright: © 2015 Govers E, et al. This is an Dietitian to Amstelring, Institution for Primary Care, The Netherlands open-access article distributed under the terms 2 Primary care dietitian to EetOké, Member of KDOO board, Scientific Advisor for Atkins International, of the Creative Commons Attribution License, The Netherlands which permits unrestricted use, distribution, and 3 Dietitian to Prima-Vita, Member of KDOO, The Netherlands reproduction in any medium, provided the original 4 Primary Care Dietitian to Bon Appetit Dietitians, The Netherlands author and source are credited. *Corresponding author: Elisabeth Govers, Cornelis van Alkemadestraat 16, 1065 AC Amsterdam, The Netherlands, E-mail:
[email protected] Abstract The successes of interventions to obtain weight loss and prevent relapse are limited. Moreover, comorbidities like type 2 diabetes mellitus, hypertension, hypercholesterolemia, hypertriglyceridemia and gout, have so far been treated as separate diseases, although mounting evidence shows that these morbidities are consequences of the failing metabolism due to insulin resistance.